APA (7th ed.) Citation

de Heer, E. C., Zois, C. E., Bridges, E., van der Vegt, B., Sheldon, H., Veldman, W. A., . . . Jalving, M. (2023). Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer. Journal of Experimental & Clinical Cancer Research (17569966), 42(1), 1. https://doi.org/10.1186/s13046-023-02715-z

Chicago Style (17th ed.) Citation

de Heer, E. C., et al. "Glycogen Synthase 1 Targeting Reveals a Metabolic Vulnerability in Triple-negative Breast Cancer." Journal of Experimental & Clinical Cancer Research (17569966) 42, no. 1 (2023): 1. https://doi.org/10.1186/s13046-023-02715-z.

MLA (9th ed.) Citation

de Heer, E. C., et al. "Glycogen Synthase 1 Targeting Reveals a Metabolic Vulnerability in Triple-negative Breast Cancer." Journal of Experimental & Clinical Cancer Research (17569966), vol. 42, no. 1, 2023, p. 1, https://doi.org/10.1186/s13046-023-02715-z.